TINAVI Medical Technologies Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 84.27 million compared to CNY 104.8 million a year ago. Revenue was CNY 84.27 million compared to CNY 104.8 million a year ago.

Net loss was CNY 82.34 million compared to CNY 63.76 million a year ago. Basic loss per share from continuing operations was CNY 0.2 compared to CNY 0.15 a year ago. Diluted loss per share from continuing operations was CNY 0.2 compared to CNY 0.15 a year ago.